A Prescription for Fraud

Federal authorities in California have announced healthcare fraud charges involving billions of dollars in allegedly fraudulent claims, including schemes targeting Medicare, Medi-Cal and private health insurance programs.

The Los Angeles healthcare fraud takedown resulted in charges against 15 defendants, including six medical professionals. Collectively, the alleged schemes involved approximately $1.8 billion in fraudulent claims, according to the U.S. Department of Justice.

Among the cases was an alleged $270 million scheme targeting Medi-Cal, California’s Medicaid program. Prosecutors allege fraudulent pharmacy claims were submitted for bogus prescriptions. Other cases involved sham substance-abuse treatment, patients allegedly billed for hospice services despite not being terminally ill, and medically unnecessary artery procedures.

The scale and variety of the allegations illustrate one of the most difficult aspects of healthcare fraud: a claim can contain familiar-looking patients, providers, procedures and billing codes while still misrepresenting whether a service was medically necessary, prescribed or even provided.

Data analytics played a role in detecting at least one of the alleged schemes involving unnecessary medical procedures. The larger 2026 National Health Care Fraud Takedown has also emphasized analytics as authorities work to identify suspicious providers and billing activity across massive numbers of claims.

The cases highlight the importance of looking beyond an individual claim. Patterns across providers, patients, prescriptions and services can reveal risks that may be difficult to recognize when transactions are reviewed in isolation.

Today’s Fraud of the Day is based on reporting from the U.S. Department of Justice and the U.S. Attorney’s Office for the Central District of California regarding healthcare fraud in 2026.